References
- Zhao DW, Yu M, Hu K, Wang W, Yang L, Wang BJ, Gao XH, Guo YM, Xu YQ, Wei YS, et al.. Prevalence of Nontraumatic Osteonecrosis of the Femoral Head and its Associated Risk Factors in the Chinese Population: Results from a Nationally Representative Survey. Chin Med J (Engl) 2015;128:2843–2850. Epub 2015/ 11/03. doi:https://doi.org/10.4103/0366-6999.168017.
- Liu L, Gao F, Sun W, Wang Y, Zhang Q, Wang B, Cheng L, Li ZR. Investigating clinical failure of core decompression with autologous bone marrow mononuclear cells grafting for the treatment of non-traumatic osteonecrosis of the femoral head. Int Orthop 2018;42:1575–1583. Epub 2018/ 04/15. doi:https://doi.org/10.1007/s00264-018-3918-7.
- Tang C, Chen L, Gu W, Du M, Li M, Chen Q, Li D. Cyclosporin A enhances the ability of trophoblasts to displace the activated human umbilical vein endothelial cell monolayers. Int J Clin Exp Pathol 2013;6:2441–2450. Epub 2013/ 11/15.
- Sadile F, Bernasconi A, Russo S, Maffulli N. Core decompression versus other joint preserving treatments for osteonecrosis of the femoral head: a meta-analysis. Br Med Bull 2016;118:33–49. Epub 2016/ 06/15. doi:https://doi.org/10.1093/bmb/ldw010.
- Wang C, Peng J, Lu S. Summary of the various treatments for osteonecrosis of the femoral head by mechanism: A review. Exp Ther Med 2014;8:700–706. Epub 2014/ 08/15. doi:https://doi.org/10.3892/etm.2014.1811.
- Kraeutler MJ, Garabekyan T, Mei-Dan O. The use of platelet-rich plasma to augment conservative and surgical treatment of hip and pelvic disorders. Muscles Ligaments Tendons J 2016;6:410–419. Epub 2017/ 01/10. doi:https://doi.org/10.32098/mltj.03.2016.19.
- LaPrade RF, Dragoo JL, Koh JL, Murray IR, Geeslin AG, Chu CR. AAOS Research Symposium Updates and Consensus: Biologic Treatment of Orthopaedic Injuries. J Am Acad Orthop Surg 2016;24:e62–78. Epub 2016/ 05/27. doi:https://doi.org/10.5435/JAAOS-D-16-00086.
- Kazem-Arki M, Kabiri M, Rad I, Roodbari NH, Hosseinpoor H, Mirzaei S, Parivar K, Hanaee-Ahvaz H. Enhancement of osteogenic differentiation of adipose-derived stem cells by PRP modified nanofibrous scaffold. Cytotechnology 2018;70:1487–1498. Epub 2018/ 08/08. doi:https://doi.org/10.1007/s10616-018-0226-4.
- Tao SC, Yuan T, Rui BY, Zhu ZZ, Guo SC, Zhang CQ. Exosomes derived from human platelet-rich plasma prevent apoptosis induced by glucocorticoid-associated endoplasmic reticulum stress in rat osteonecrosis of the femoral head via the Akt/Bad/Bcl-2 signal pathway. Theranostics 2017;7:733–750. Epub 2017/ 03/04. doi:https://doi.org/10.7150/thno.17450.
- Zhang XL, Shi KQ, Jia PT, Jiang LH, Liu YH, Chen X, Zhou ZY, Li YX, Wang LS. Effects of platelet-rich plasma on angiogenesis and osteogenesis-associated factors in rabbits with avascular necrosis of the femoral head. Eur Rev Med Pharmacol Sci 2018;22:2143–2152. Epub 2018/ 04/25. doi:https://doi.org/10.26355/eurrev_201804_14748.
- van der Jagt D, Mokete L, Pietrzak J, Zalavras CG, Lieberman JR. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg 2015;23:69–70. Epub 2015/ 01/28. doi:https://doi.org/10.5435/JAAOS-D-14-00431.
- Laver L, Marom N, Dnyanesh L, Mei-Dan O, Espregueira-Mendes J, Gobbi A. PRP for Degenerative Cartilage Disease: A Systematic Review of Clinical Studies. Cartilage 2017;8:341–364. Epub 2017/ 03/21. doi:https://doi.org/10.1177/1947603516670709.
- Zheng LZ, Wang JL, Kong L, Huang L, Tian L, Pang QQ, Wang XL, Qin L. Steroid-associated osteonecrosis animal model in rats. J Orthop Transl 2018;13:13–24. Epub 2018/ 04/18. doi:https://doi.org/10.1016/j.jot.2018.01.003.
- Domitrovic R, Rashed K, Cvijanovic O, Vladimir-Knezevic S, Skoda M, Visnic A. Myricitrin exhibits antioxidant, anti-inflammatory and antifibrotic activity in carbon tetrachloride-intoxicated mice. Chem Biol Interact 2015;230:21–29. Epub 2015/ 02/07. doi:https://doi.org/10.1016/j.cbi.2015.01.030.
- Wang D, Wang G, Liu M, Sun L, Zong W, Jiang H, Zhang H, Li H, Gong J, Sun S. A novel animal model of osteonecrosis of the femoral head induced using a magnetic resonance imaging-guided argon-helium cryotherapy system. Exp Ther Med 2014;7:1525–1528. Epub 2014/ 06/14. doi:https://doi.org/10.3892/etm.2014.1625.
- Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy 2012;28:429–439. Epub 2012/ 01/31. doi:https://doi.org/10.1016/j.arthro.2011.10.018.
- Vannini F, Di Matteo B, Filardo G. Platelet-rich plasma to treat ankle cartilage pathology - from translational potential to clinical evidence: a systematic review. J Exp Orthop 2015;2:2. Epub 2016/ 02/26. doi:https://doi.org/10.1186/s40634-015-0019-z.
- Ahmed M, Reffat SA, Hassan A, Eskander F. Platelet-Rich Plasma for the Treatment of Clean Diabetic Foot Ulcers. Ann Vasc Surg 2017;38:206–211. doi:https://doi.org/10.1016/j.avsg.2016.04.023.
- Oryan A, Alidadi S, Moshiri A. Platelet-rich plasma for bone healing and regeneration. Expert Opin Biol Ther 2016;16:213–232. Epub 2015/ 11/13. doi:https://doi.org/10.1517/14712598.2016.1118458.
- Wang B, Geng Q, Hu J, Shao J, Ruan J, Zheng J. Platelet-rich plasma reduces skin flap inflammatory cells infiltration and improves survival rates through induction of angiogenesis: An experiment in rabbits. J Plast Surg Hand Surg 2016;50:239–245. Epub 2016/ 04/05. doi:https://doi.org/10.3109/2000656X.2016.1159216.
- Tong S, Yin J, Liu J. Platelet-rich plasma has beneficial effects in mice with osteonecrosis of the femoral head by promoting angiogenesis. Exp Ther Med 2018;15:1781–1788. Epub 2018/ 02/13. doi:https://doi.org/10.3892/etm.2017.5655.
- Corrado A, Neve A, Macchiarola A, Gaudio A, Marucci A, Cantatore FP. RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects. J Rheumatol 2013;40:684–694. Epub 2013/ 03/05. doi:https://doi.org/10.3899/jrheum.120845.
- Yu Z, Fan L, Li J, Ge Z, Dang X, Wang K. Lithium prevents rat steroid-related osteonecrosis of the femoral head by beta-catenin activation. Endocrine 2016;52:380–390. Epub 2015/ 10/16. doi:https://doi.org/10.1007/s12020-015-0747-y.
- Zhang C, Zou YL, Ma J, Dang XQ, Wang KZ. Apoptosis associated with Wnt/beta-catenin pathway leads to steroid-induced avascular necrosis of femoral head. BMC Musculoskelet Disord 2015;16:132. Epub 2015/ 06/04. doi:https://doi.org/10.1186/s12891-015-0606-2.
- Bose R, Moors M, Tofighi R, Cascante A, Hermanson O, Ceccatelli S. Glucocorticoids induce long-lasting effects in neural stem cells resulting in senescence-related alterations. Cell Death Dis 2010;1:e92–e92. doi:https://doi.org/10.1038/cddis.2010.60.
- Guo X, Yang W, Ni J, He M, Yang L. A role for suppressed bone formation favoring catch-up fat in the pathophysiology of catch-up growth after food restriction. Eur J Nutr 2011;50:645–655. Epub 2011/ 02/22. doi:https://doi.org/10.1007/s00394-011-0174-7.
- Jiang Y, Zhang Y, Zhang H, Zhu B, Li P, Lu C, Xu Y, Chen W, Lin N. Pravastatin prevents steroid-induced osteonecrosis in rats by suppressing PPARgamma expression and activating Wnt signaling pathway. Exp Biol Med (Maywood) 2014;239:347–355. Epub 2014/ 02/11. doi:https://doi.org/10.1177/1535370213519215.
- Yu Z, Fan L, Li J, Ge Z, Dang X, Wang K. Lithium chloride attenuates the abnormal osteogenic/adipogenic differentiation of bone marrow-derived mesenchymal stem cells obtained from rats with steroid-related osteonecrosis by activating the beta-catenin pathway. Int J Mol Med 2015;36:1264–1272. Epub 2015/ 09/10. doi:https://doi.org/10.3892/ijmm.2015.2340.
- Wang T, Teng S, Zhang Y, Wang F, Ding H, Guo L. Role of mesenchymal stem cells on differentiation in steroid-induced avascular necrosis of the femoral head. Exp Ther Med 2017;13:669–675. Epub 2017/ 03/30. doi:https://doi.org/10.3892/etm.2016.3991.
- Li J, Li Y, Wang Y, Liu M, Zhao G. Preventive effects of siRNA targeting PPARgamma gene on steroid-induced osteonecrosis in rabbits. Connect Tissue Res 2014;55:322–330. Epub 2014/ 07/08. doi:https://doi.org/10.3109/03008207.2014.941106.
- Folkman J, Ingber DE. Angiostatic steroids. Method of discovery and mechanism of action. Ann Surg 1987;206:374–383. Epub 1987/ 09/01. doi:https://doi.org/10.1097/00000658-198709000-00016.
- Hou J, Wang L, Wu Q, Zheng G, Long H, Wu H, Zhou C, Guo T, Zhong T, Wang L, et al.. Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p. Stem Cell Res Ther 2018;9:109. Epub 2018/ 04/21. doi:https://doi.org/10.1186/s13287-018-0861-x.
- Muraoka N, Shum L, Fukumoto S, Nomura T, Ohishi M, Nonaka K. Transforming growth factor-beta3 promotes mesenchymal cell proliferation and angiogenesis mediated by the enhancement of cyclin D1, Flk-1, and CD31 gene expression during CL/Fr mouse lip fusion. Birth Defects Res A Clin Mol Teratol 2005;73:956–965. Epub 2005/ 12/03. doi:https://doi.org/10.1002/bdra.20191.
- Lertkiatmongkol P, Liao D, Mei H, Hu Y, Newman PJ. Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31). Curr Opin Hematol 2016;23:253–259. Epub 2016/ 04/08. doi:https://doi.org/10.1097/MOH.0000000000000239.